What's new

Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised

Apr 2, 2025 - 15:45
 0
Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

FDA’s Chief Medical Officer Hilary Marston is out amid mass layoffs

Next Article

Human medicines European public assessment report (EPAR): Jardiance, empaglifloz...

Related Posts

Herbal medicinal product: Salviae officinalis foliumArray, F: Assessment finalised

Herbal medicinal product: Salviae officinalis foliumArr...

Feb 14, 2025  0

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Date of authorisation: 20/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 17, 2025  0